About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Michigan | 20,100 Studies Near You

Clinical TrialsMichigan

Clinical Trials in Michigan

Discover 20,100 clinical trials near Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 2361-2380 of 20,100 trials

CompletedPreventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in RemissionThe purpose of this research study is to evaluate a new investigational drug to prevent reoccurrence of neuroblastoma that is in remission. This study drug is called DFMO.NCT02395666·Phoenix, Arizona and 21 others

Find Trials by Condition in Michigan

Breast Cancerin Michigan Lung Cancerin Michigan Prostate Cancerin Michigan Colorectal Cancerin Michigan Melanomain Michigan Leukemiain Michigan Lymphomain Michigan Pancreatic Cancerin Michigan Ovarian Cancerin Michigan Brain Cancerin Michigan Diabetes

Data from ClinicalTrials.govTerms

RecruitingA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseThis study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg…NCT06283966·Athens, Alabama and 921 others

UnknownUse of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)The SPECTacular study will enroll patients who are already undergoing a FDA approved PSMA-targeted Radioligand treatment cycle.NCT05823402·Grand Rapids, Michigan

RecruitingHIP Fracture Accelerated Surgical TreaTment And Care tracK 2 TrialThe HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute…NCT04743765·Chandler, Arizona and 76 others

CompletedStudy Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous UrticariaThis study is being conducted to evaluate the efficacy and safety of povorcitinib in adults with CSU that is inadequately controlled using SOC treatments.NCT05936567·Birmingham, Alabama and 41 others

CompletedRotation Medical Bioinductive Implant Database RegistryThe purpose of this clinical registry is to prospectively collect and compare preoperative and postoperative patient-reported data using validated shoulder-specific and…NCT02784600·Orange, California and 18 others

CompletedMitral Implantation of TRAnscatheter vaLvesThe purpose of this trial is to establish the safety and feasibility of the Edwards SAPIEN XT™and SAPIEN 3™ device and delivery systems in patients with severe symptomatic…NCT02370511·Phoenix, Arizona and 14 others

CompletedGemcitabine and Cisplatin in Treating Patients With Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00002998·Scottsdale, Arizona and 19 others

RecruitingShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabThis phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive…NCT06876714·Phoenix, Arizona and 701 others

RecruitingDose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid TumorsThis is a First-in-Human, Phase 1, Dose-Escalation and Dose-Expansion study of HM16390, as a single agent and in combination with pembrolizumab to assess safety, tolerability…NCT06724016·Los Angeles, California and 7 others

CompletedMT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal WomenThe purpose of this study is to assess the efficacy and safety of MT-8554 for treatment of vasomotor symptoms (VMS) associated with menopause.NCT03291067·Birmingham, Alabama and 62 others

TerminatedPhase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerThis study will compare the efficacy of the investigational agent sitravatinib in combination with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have…NCT03906071·Birmingham, Alabama and 260 others

CompletedLong-Term Safety Of PF-00547659 In Ulcerative ColitisSubjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 144 weeks of open-label treatment to evaluate the long-term…NCT01771809·Scottsdale, Arizona and 98 others

CompletedDoxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial CancerThis randomized phase III trial compares how well two different combination chemotherapy regimens (doxorubicin hydrochloride, cisplatin, and paclitaxel versus carboplatin and…NCT00063999·Birmingham, Alabama and 649 others

CompletedDose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe AsthmaThis was a parallel, Phase 2, global, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, four-arms study for treatment.NCT05421598·La Jolla, California and 112 others

CompletedPhase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and ChemotherapyThe purpose is to see how quickly two different types of prostate cancer participants respond when taking enzastaurin.NCT00428714·Los Angeles, California and 10 others

CompletedTolvaptan Extension Study in Participants With ADPKDTo demonstrate whether tolvaptan modifies ADPKD progression as measured by changes from Baseline (from Study 156-04-251) in total kidney volume (TKV) and renal function.NCT01214421·Mobile, Alabama and 96 others

CompletedDevelopment of Inflammatory Disease Model Protein, Genetic and Microbial BiomarkersThe purpose of this study is to determine if certain levels of proteins lead to inflammation of the gums. One example of such proteins being studied is called Interleukin 1 (IL-1).NCT00980525·Ann Arbor, Michigan

TerminatedA Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2A Study of XMT-2056 in advanced/recurrent solid tumors that express HER2.NCT05514717·Los Angeles, California and 13 others

RecruitingA Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)Researchers are looking for new ways to treat children with relapsed or refractory solid tumors: * Relapsed means the cancer came back after treatment * Refractory means the…NCT07630974·Los Angeles, California and 34 others

PreviousPage 119 of 1005Next

in Michigan

Heart Diseasein Michigan